Advertisement

Index by author

August 01, 2001; Volume 29,Issue 8

A

  1. Allen, Scott W.

    1. The Use of a High-Volume Screening Procedure to Assess the Effects of Dietary Flavonoids on Human CYP1A1 Expression
      Scott W. Allen, Lisa Mueller, Susanne N. Williams, Linda C. Quattrochi and Judy Raucy
      Drug Metabolism and Disposition August 2001, 29 (8) 1074-1079;

  2. Apte, Udayan

    1. Cytochrome P4502E1 Induction Increases Thioacetamide Liver Injury in Diet-Restricted Rats
      Shashi K. Ramaiah, Udayan Apte and Harihara M. Mehendale
      Drug Metabolism and Disposition August 2001, 29 (8) 1088-1095;

B

  1. Brown, Alethia

    1. Biotransformation, Excretion Kinetics, and Tissue Distribution of an N-Pyrrolo[1,2-c]imidazolylphenyl Sulfonamide Herbicide in Rats
      Mehran F. Moghaddam, Alethia Brown, Boiana O. Budevska, Zamas Lam and William G. Payne
      Drug Metabolism and Disposition August 2001, 29 (8) 1162-1170;

  2. Bruss, J. B.

    1. Pharmacokinetics, Metabolism, and Excretion of Linezolid following an Oral Dose of [14C]Linezolid to Healthy Human Subjects
      J. G. Slatter, D. J. Stalker, K. L. Feenstra, I. R. Welshman, J. B. Bruss, J. P. Sams, M. G. Johnson, P. E. Sanders, M. J. Hauer, P. E. Fagerness, R. P. Stryd, G. W. Peng and E. M. Shobe
      Drug Metabolism and Disposition August 2001, 29 (8) 1136-1145;

  3. Budevska, Boiana O.

    1. Biotransformation, Excretion Kinetics, and Tissue Distribution of an N-Pyrrolo[1,2-c]imidazolylphenyl Sulfonamide Herbicide in Rats
      Mehran F. Moghaddam, Alethia Brown, Boiana O. Budevska, Zamas Lam and William G. Payne
      Drug Metabolism and Disposition August 2001, 29 (8) 1162-1170;

C

  1. Casciano, Christopher N.

    1. Evaluation of the Interaction of Loratadine and desloratadine with P-glycoprotein
      Er-jia Wang, Christopher N. Casciano, Robert P. Clement and William W. Johnson
      Drug Metabolism and Disposition August 2001, 29 (8) 1080-1083;

  2. Clement, Robert P.

    1. Evaluation of the Interaction of Loratadine and desloratadine with P-glycoprotein
      Er-jia Wang, Christopher N. Casciano, Robert P. Clement and William W. Johnson
      Drug Metabolism and Disposition August 2001, 29 (8) 1080-1083;

D

  1. Davis, B. A.

    1. Inhibition of Rat Liver Microsomal CYP1A2 and CYP2B1 Activity by N-(2-Heptyl)-N-methyl-propargylamine and by N-(2-Heptyl)-propargylamine
      L. E. Dyck and B. A. Davis
      Drug Metabolism and Disposition August 2001, 29 (8) 1156-1161;

  2. Duanmu, Zhengbo

    1. Transcriptional Regulation of Rat Hepatic Aryl Sulfotransferase (SULT1A1) Gene Expression by Glucocorticoids
      Zhengbo Duanmu, Thomas A. Kocarek and Melissa Runge-Morris
      Drug Metabolism and Disposition August 2001, 29 (8) 1130-1135;

  3. Dyck, L. E.

    1. Inhibition of Rat Liver Microsomal CYP1A2 and CYP2B1 Activity by N-(2-Heptyl)-N-methyl-propargylamine and by N-(2-Heptyl)-propargylamine
      L. E. Dyck and B. A. Davis
      Drug Metabolism and Disposition August 2001, 29 (8) 1156-1161;

E

  1. Elovaara, Eivor

    1. Glucuronidation of 1-Hydroxypyrene by Human Liver Microsomes and Human UDP-Glucuronosyltransferases UGT1A6, UGT1A7, and UGT1A9: Development of a High-Sensitivity Glucuronidation Assay for Human Tissue
      Leena Luukkanen, Jouni Mikkola, Tarja Forsman, Päivi Taavitsainen, Jyrki Taskinen and Eivor Elovaara
      Drug Metabolism and Disposition August 2001, 29 (8) 1096-1101;

F

  1. Fagerness, P. E.

    1. Pharmacokinetics, Metabolism, and Excretion of Linezolid following an Oral Dose of [14C]Linezolid to Healthy Human Subjects
      J. G. Slatter, D. J. Stalker, K. L. Feenstra, I. R. Welshman, J. B. Bruss, J. P. Sams, M. G. Johnson, P. E. Sanders, M. J. Hauer, P. E. Fagerness, R. P. Stryd, G. W. Peng and E. M. Shobe
      Drug Metabolism and Disposition August 2001, 29 (8) 1136-1145;

  2. Faucette, Stephanie R.

    1. Evaluation of the Contribution of Cytochrome P450 3A4 to Human Liver Microsomal Bupropion Hydroxylation
      Stephanie R. Faucette, Roy L. Hawke, Stacy S. Shord, Edward L. Lecluyse and Celeste M. Lindley
      Drug Metabolism and Disposition August 2001, 29 (8) 1123-1129;

  3. Feenstra, K. L.

    1. Pharmacokinetics, Metabolism, and Excretion of Linezolid following an Oral Dose of [14C]Linezolid to Healthy Human Subjects
      J. G. Slatter, D. J. Stalker, K. L. Feenstra, I. R. Welshman, J. B. Bruss, J. P. Sams, M. G. Johnson, P. E. Sanders, M. J. Hauer, P. E. Fagerness, R. P. Stryd, G. W. Peng and E. M. Shobe
      Drug Metabolism and Disposition August 2001, 29 (8) 1136-1145;

  4. Forsman, Tarja

    1. Glucuronidation of 1-Hydroxypyrene by Human Liver Microsomes and Human UDP-Glucuronosyltransferases UGT1A6, UGT1A7, and UGT1A9: Development of a High-Sensitivity Glucuronidation Assay for Human Tissue
      Leena Luukkanen, Jouni Mikkola, Tarja Forsman, Päivi Taavitsainen, Jyrki Taskinen and Eivor Elovaara
      Drug Metabolism and Disposition August 2001, 29 (8) 1096-1101;

G

  1. Giancarlo, Gina M.

    1. Escitalopram (S-Citalopram) and Its Metabolites in Vitro: Cytochromes Mediating Biotransformation, Inhibitory Effects, and Comparison to R-Citalopram
      Lisa L. von Moltke, David J. Greenblatt, Gina M. Giancarlo, Brian W. Granda, Jerold S. Harmatz and Richard I. Shader
      Drug Metabolism and Disposition August 2001, 29 (8) 1102-1109;

  2. Granda, Brian W.

    1. Escitalopram (S-Citalopram) and Its Metabolites in Vitro: Cytochromes Mediating Biotransformation, Inhibitory Effects, and Comparison to R-Citalopram
      Lisa L. von Moltke, David J. Greenblatt, Gina M. Giancarlo, Brian W. Granda, Jerold S. Harmatz and Richard I. Shader
      Drug Metabolism and Disposition August 2001, 29 (8) 1102-1109;

  3. Greenblatt, David J.

    1. Escitalopram (S-Citalopram) and Its Metabolites in Vitro: Cytochromes Mediating Biotransformation, Inhibitory Effects, and Comparison to R-Citalopram
      Lisa L. von Moltke, David J. Greenblatt, Gina M. Giancarlo, Brian W. Granda, Jerold S. Harmatz and Richard I. Shader
      Drug Metabolism and Disposition August 2001, 29 (8) 1102-1109;

H

  1. Halpert, James R.

    1. James R. Halpert
      Drug Metabolism and Disposition August 2001, 29 (8) 1073;

  2. Harmatz, Jerold S.

    1. Escitalopram (S-Citalopram) and Its Metabolites in Vitro: Cytochromes Mediating Biotransformation, Inhibitory Effects, and Comparison to R-Citalopram
      Lisa L. von Moltke, David J. Greenblatt, Gina M. Giancarlo, Brian W. Granda, Jerold S. Harmatz and Richard I. Shader
      Drug Metabolism and Disposition August 2001, 29 (8) 1102-1109;

  3. Hauer, M. J.

    1. Pharmacokinetics, Metabolism, and Excretion of Linezolid following an Oral Dose of [14C]Linezolid to Healthy Human Subjects
      J. G. Slatter, D. J. Stalker, K. L. Feenstra, I. R. Welshman, J. B. Bruss, J. P. Sams, M. G. Johnson, P. E. Sanders, M. J. Hauer, P. E. Fagerness, R. P. Stryd, G. W. Peng and E. M. Shobe
      Drug Metabolism and Disposition August 2001, 29 (8) 1136-1145;

  4. Hawke, Roy L.

    1. Evaluation of the Contribution of Cytochrome P450 3A4 to Human Liver Microsomal Bupropion Hydroxylation
      Stephanie R. Faucette, Roy L. Hawke, Stacy S. Shord, Edward L. Lecluyse and Celeste M. Lindley
      Drug Metabolism and Disposition August 2001, 29 (8) 1123-1129;

I

  1. Inoue, Hiroki

    1. Bisphenol A Glucuronide, a Major Metabolite in Rat Bile after Liver Perfusion
      Hiroki Inoue, Hiroshi Yokota, Tsunehisa Makino, Akira Yuasa and Seiyu Kato
      Drug Metabolism and Disposition August 2001, 29 (8) 1084-1087;

J

  1. Johnson, M. G.

    1. Pharmacokinetics, Metabolism, and Excretion of Linezolid following an Oral Dose of [14C]Linezolid to Healthy Human Subjects
      J. G. Slatter, D. J. Stalker, K. L. Feenstra, I. R. Welshman, J. B. Bruss, J. P. Sams, M. G. Johnson, P. E. Sanders, M. J. Hauer, P. E. Fagerness, R. P. Stryd, G. W. Peng and E. M. Shobe
      Drug Metabolism and Disposition August 2001, 29 (8) 1136-1145;

  2. Johnson, William W.

    1. Evaluation of the Interaction of Loratadine and desloratadine with P-glycoprotein
      Er-jia Wang, Christopher N. Casciano, Robert P. Clement and William W. Johnson
      Drug Metabolism and Disposition August 2001, 29 (8) 1080-1083;

K

  1. Kato, Seiyu

    1. Bisphenol A Glucuronide, a Major Metabolite in Rat Bile after Liver Perfusion
      Hiroki Inoue, Hiroshi Yokota, Tsunehisa Makino, Akira Yuasa and Seiyu Kato
      Drug Metabolism and Disposition August 2001, 29 (8) 1084-1087;

  2. Kocarek, Thomas A.

    1. Transcriptional Regulation of Rat Hepatic Aryl Sulfotransferase (SULT1A1) Gene Expression by Glucocorticoids
      Zhengbo Duanmu, Thomas A. Kocarek and Melissa Runge-Morris
      Drug Metabolism and Disposition August 2001, 29 (8) 1130-1135;

L

  1. Lake, Brian G.

    1. Identification of Cytochrome P-450 Isoforms Responsible for cis-Tramadol Metabolism in Human Liver Microsomes
      Vangala Subrahmanyam, Anthony B. Renwick, David G. Walters, Philip J. Young, Roger J. Price, Alfred P. Tonelli and Brian G. Lake
      Drug Metabolism and Disposition August 2001, 29 (8) 1146-1155;

  2. Lam, Zamas

    1. Biotransformation, Excretion Kinetics, and Tissue Distribution of an N-Pyrrolo[1,2-c]imidazolylphenyl Sulfonamide Herbicide in Rats
      Mehran F. Moghaddam, Alethia Brown, Boiana O. Budevska, Zamas Lam and William G. Payne
      Drug Metabolism and Disposition August 2001, 29 (8) 1162-1170;

  3. Lecluyse, Edward L.

    1. Evaluation of the Contribution of Cytochrome P450 3A4 to Human Liver Microsomal Bupropion Hydroxylation
      Stephanie R. Faucette, Roy L. Hawke, Stacy S. Shord, Edward L. Lecluyse and Celeste M. Lindley
      Drug Metabolism and Disposition August 2001, 29 (8) 1123-1129;

  4. Lindley, Celeste M.

    1. Evaluation of the Contribution of Cytochrome P450 3A4 to Human Liver Microsomal Bupropion Hydroxylation
      Stephanie R. Faucette, Roy L. Hawke, Stacy S. Shord, Edward L. Lecluyse and Celeste M. Lindley
      Drug Metabolism and Disposition August 2001, 29 (8) 1123-1129;

  5. Luukkanen, Leena

    1. Glucuronidation of 1-Hydroxypyrene by Human Liver Microsomes and Human UDP-Glucuronosyltransferases UGT1A6, UGT1A7, and UGT1A9: Development of a High-Sensitivity Glucuronidation Assay for Human Tissue
      Leena Luukkanen, Jouni Mikkola, Tarja Forsman, Päivi Taavitsainen, Jyrki Taskinen and Eivor Elovaara
      Drug Metabolism and Disposition August 2001, 29 (8) 1096-1101;

M

  1. Makino, Tsunehisa

    1. Bisphenol A Glucuronide, a Major Metabolite in Rat Bile after Liver Perfusion
      Hiroki Inoue, Hiroshi Yokota, Tsunehisa Makino, Akira Yuasa and Seiyu Kato
      Drug Metabolism and Disposition August 2001, 29 (8) 1084-1087;

  2. Mehendale, Harihara M.

    1. Cytochrome P4502E1 Induction Increases Thioacetamide Liver Injury in Diet-Restricted Rats
      Shashi K. Ramaiah, Udayan Apte and Harihara M. Mehendale
      Drug Metabolism and Disposition August 2001, 29 (8) 1088-1095;

  3. Mikkola, Jouni

    1. Glucuronidation of 1-Hydroxypyrene by Human Liver Microsomes and Human UDP-Glucuronosyltransferases UGT1A6, UGT1A7, and UGT1A9: Development of a High-Sensitivity Glucuronidation Assay for Human Tissue
      Leena Luukkanen, Jouni Mikkola, Tarja Forsman, Päivi Taavitsainen, Jyrki Taskinen and Eivor Elovaara
      Drug Metabolism and Disposition August 2001, 29 (8) 1096-1101;

  4. Moghaddam, Mehran F.

    1. Biotransformation, Excretion Kinetics, and Tissue Distribution of an N-Pyrrolo[1,2-c]imidazolylphenyl Sulfonamide Herbicide in Rats
      Mehran F. Moghaddam, Alethia Brown, Boiana O. Budevska, Zamas Lam and William G. Payne
      Drug Metabolism and Disposition August 2001, 29 (8) 1162-1170;

  5. Mueller, Lisa

    1. The Use of a High-Volume Screening Procedure to Assess the Effects of Dietary Flavonoids on Human CYP1A1 Expression
      Scott W. Allen, Lisa Mueller, Susanne N. Williams, Linda C. Quattrochi and Judy Raucy
      Drug Metabolism and Disposition August 2001, 29 (8) 1074-1079;

N

  1. Nakajima, Miki

    1. Inhibition and Inactivation of Human Cytochrome P450 Isoforms by Phenethyl Isothiocyanate
      Miki Nakajima, Ryoko Yoshida, Noriaki Shimada, Hiroshi Yamazaki and Tsuyoshi Yokoi
      Drug Metabolism and Disposition August 2001, 29 (8) 1110-1113;

  2. Nelson, Wendel L.

    1. Carbinolamines, Imines, and Oxazolidines from Fluorinated Propranolol Analogs. 19F NMR and Mass Spectral Characterization and Evidence for Formation as Intermediates in Cytochrome P450-Catalyzed N-Dealkylation
      Alana L. Upthagrove and Wendel L. Nelson
      Drug Metabolism and Disposition August 2001, 29 (8) 1114-1122;

P

  1. Payne, William G.

    1. Biotransformation, Excretion Kinetics, and Tissue Distribution of an N-Pyrrolo[1,2-c]imidazolylphenyl Sulfonamide Herbicide in Rats
      Mehran F. Moghaddam, Alethia Brown, Boiana O. Budevska, Zamas Lam and William G. Payne
      Drug Metabolism and Disposition August 2001, 29 (8) 1162-1170;

  2. Peng, G. W.

    1. Pharmacokinetics, Metabolism, and Excretion of Linezolid following an Oral Dose of [14C]Linezolid to Healthy Human Subjects
      J. G. Slatter, D. J. Stalker, K. L. Feenstra, I. R. Welshman, J. B. Bruss, J. P. Sams, M. G. Johnson, P. E. Sanders, M. J. Hauer, P. E. Fagerness, R. P. Stryd, G. W. Peng and E. M. Shobe
      Drug Metabolism and Disposition August 2001, 29 (8) 1136-1145;

  3. Price, Roger J.

    1. Identification of Cytochrome P-450 Isoforms Responsible for cis-Tramadol Metabolism in Human Liver Microsomes
      Vangala Subrahmanyam, Anthony B. Renwick, David G. Walters, Philip J. Young, Roger J. Price, Alfred P. Tonelli and Brian G. Lake
      Drug Metabolism and Disposition August 2001, 29 (8) 1146-1155;

Q

  1. Quattrochi, Linda C.

    1. The Use of a High-Volume Screening Procedure to Assess the Effects of Dietary Flavonoids on Human CYP1A1 Expression
      Scott W. Allen, Lisa Mueller, Susanne N. Williams, Linda C. Quattrochi and Judy Raucy
      Drug Metabolism and Disposition August 2001, 29 (8) 1074-1079;

R

  1. Ramaiah, Shashi K.

    1. Cytochrome P4502E1 Induction Increases Thioacetamide Liver Injury in Diet-Restricted Rats
      Shashi K. Ramaiah, Udayan Apte and Harihara M. Mehendale
      Drug Metabolism and Disposition August 2001, 29 (8) 1088-1095;

  2. Raucy, Judy

    1. The Use of a High-Volume Screening Procedure to Assess the Effects of Dietary Flavonoids on Human CYP1A1 Expression
      Scott W. Allen, Lisa Mueller, Susanne N. Williams, Linda C. Quattrochi and Judy Raucy
      Drug Metabolism and Disposition August 2001, 29 (8) 1074-1079;

  3. Renwick, Anthony B.

    1. Identification of Cytochrome P-450 Isoforms Responsible for cis-Tramadol Metabolism in Human Liver Microsomes
      Vangala Subrahmanyam, Anthony B. Renwick, David G. Walters, Philip J. Young, Roger J. Price, Alfred P. Tonelli and Brian G. Lake
      Drug Metabolism and Disposition August 2001, 29 (8) 1146-1155;

  4. Runge-Morris, Melissa

    1. Transcriptional Regulation of Rat Hepatic Aryl Sulfotransferase (SULT1A1) Gene Expression by Glucocorticoids
      Zhengbo Duanmu, Thomas A. Kocarek and Melissa Runge-Morris
      Drug Metabolism and Disposition August 2001, 29 (8) 1130-1135;

S

  1. Sams, J. P.

    1. Pharmacokinetics, Metabolism, and Excretion of Linezolid following an Oral Dose of [14C]Linezolid to Healthy Human Subjects
      J. G. Slatter, D. J. Stalker, K. L. Feenstra, I. R. Welshman, J. B. Bruss, J. P. Sams, M. G. Johnson, P. E. Sanders, M. J. Hauer, P. E. Fagerness, R. P. Stryd, G. W. Peng and E. M. Shobe
      Drug Metabolism and Disposition August 2001, 29 (8) 1136-1145;

  2. Sanders, P. E.

    1. Pharmacokinetics, Metabolism, and Excretion of Linezolid following an Oral Dose of [14C]Linezolid to Healthy Human Subjects
      J. G. Slatter, D. J. Stalker, K. L. Feenstra, I. R. Welshman, J. B. Bruss, J. P. Sams, M. G. Johnson, P. E. Sanders, M. J. Hauer, P. E. Fagerness, R. P. Stryd, G. W. Peng and E. M. Shobe
      Drug Metabolism and Disposition August 2001, 29 (8) 1136-1145;

  3. Shader, Richard I.

    1. Escitalopram (S-Citalopram) and Its Metabolites in Vitro: Cytochromes Mediating Biotransformation, Inhibitory Effects, and Comparison to R-Citalopram
      Lisa L. von Moltke, David J. Greenblatt, Gina M. Giancarlo, Brian W. Granda, Jerold S. Harmatz and Richard I. Shader
      Drug Metabolism and Disposition August 2001, 29 (8) 1102-1109;

  4. Shimada, Noriaki

    1. Inhibition and Inactivation of Human Cytochrome P450 Isoforms by Phenethyl Isothiocyanate
      Miki Nakajima, Ryoko Yoshida, Noriaki Shimada, Hiroshi Yamazaki and Tsuyoshi Yokoi
      Drug Metabolism and Disposition August 2001, 29 (8) 1110-1113;

  5. Shobe, E. M.

    1. Pharmacokinetics, Metabolism, and Excretion of Linezolid following an Oral Dose of [14C]Linezolid to Healthy Human Subjects
      J. G. Slatter, D. J. Stalker, K. L. Feenstra, I. R. Welshman, J. B. Bruss, J. P. Sams, M. G. Johnson, P. E. Sanders, M. J. Hauer, P. E. Fagerness, R. P. Stryd, G. W. Peng and E. M. Shobe
      Drug Metabolism and Disposition August 2001, 29 (8) 1136-1145;

  6. Shord, Stacy S.

    1. Evaluation of the Contribution of Cytochrome P450 3A4 to Human Liver Microsomal Bupropion Hydroxylation
      Stephanie R. Faucette, Roy L. Hawke, Stacy S. Shord, Edward L. Lecluyse and Celeste M. Lindley
      Drug Metabolism and Disposition August 2001, 29 (8) 1123-1129;

  7. Slatter, J. G.

    1. Pharmacokinetics, Metabolism, and Excretion of Linezolid following an Oral Dose of [14C]Linezolid to Healthy Human Subjects
      J. G. Slatter, D. J. Stalker, K. L. Feenstra, I. R. Welshman, J. B. Bruss, J. P. Sams, M. G. Johnson, P. E. Sanders, M. J. Hauer, P. E. Fagerness, R. P. Stryd, G. W. Peng and E. M. Shobe
      Drug Metabolism and Disposition August 2001, 29 (8) 1136-1145;

  8. Stalker, D. J.

    1. Pharmacokinetics, Metabolism, and Excretion of Linezolid following an Oral Dose of [14C]Linezolid to Healthy Human Subjects
      J. G. Slatter, D. J. Stalker, K. L. Feenstra, I. R. Welshman, J. B. Bruss, J. P. Sams, M. G. Johnson, P. E. Sanders, M. J. Hauer, P. E. Fagerness, R. P. Stryd, G. W. Peng and E. M. Shobe
      Drug Metabolism and Disposition August 2001, 29 (8) 1136-1145;

  9. Stryd, R. P.

    1. Pharmacokinetics, Metabolism, and Excretion of Linezolid following an Oral Dose of [14C]Linezolid to Healthy Human Subjects
      J. G. Slatter, D. J. Stalker, K. L. Feenstra, I. R. Welshman, J. B. Bruss, J. P. Sams, M. G. Johnson, P. E. Sanders, M. J. Hauer, P. E. Fagerness, R. P. Stryd, G. W. Peng and E. M. Shobe
      Drug Metabolism and Disposition August 2001, 29 (8) 1136-1145;

  10. Subrahmanyam, Vangala

    1. Identification of Cytochrome P-450 Isoforms Responsible for cis-Tramadol Metabolism in Human Liver Microsomes
      Vangala Subrahmanyam, Anthony B. Renwick, David G. Walters, Philip J. Young, Roger J. Price, Alfred P. Tonelli and Brian G. Lake
      Drug Metabolism and Disposition August 2001, 29 (8) 1146-1155;

T

  1. Taavitsainen, Päivi

    1. Glucuronidation of 1-Hydroxypyrene by Human Liver Microsomes and Human UDP-Glucuronosyltransferases UGT1A6, UGT1A7, and UGT1A9: Development of a High-Sensitivity Glucuronidation Assay for Human Tissue
      Leena Luukkanen, Jouni Mikkola, Tarja Forsman, Päivi Taavitsainen, Jyrki Taskinen and Eivor Elovaara
      Drug Metabolism and Disposition August 2001, 29 (8) 1096-1101;

  2. Taskinen, Jyrki

    1. Glucuronidation of 1-Hydroxypyrene by Human Liver Microsomes and Human UDP-Glucuronosyltransferases UGT1A6, UGT1A7, and UGT1A9: Development of a High-Sensitivity Glucuronidation Assay for Human Tissue
      Leena Luukkanen, Jouni Mikkola, Tarja Forsman, Päivi Taavitsainen, Jyrki Taskinen and Eivor Elovaara
      Drug Metabolism and Disposition August 2001, 29 (8) 1096-1101;

  3. Tonelli, Alfred P.

    1. Identification of Cytochrome P-450 Isoforms Responsible for cis-Tramadol Metabolism in Human Liver Microsomes
      Vangala Subrahmanyam, Anthony B. Renwick, David G. Walters, Philip J. Young, Roger J. Price, Alfred P. Tonelli and Brian G. Lake
      Drug Metabolism and Disposition August 2001, 29 (8) 1146-1155;

U

  1. Upthagrove, Alana L.

    1. Carbinolamines, Imines, and Oxazolidines from Fluorinated Propranolol Analogs. 19F NMR and Mass Spectral Characterization and Evidence for Formation as Intermediates in Cytochrome P450-Catalyzed N-Dealkylation
      Alana L. Upthagrove and Wendel L. Nelson
      Drug Metabolism and Disposition August 2001, 29 (8) 1114-1122;

V

  1. von Moltke, Lisa L.

    1. Escitalopram (S-Citalopram) and Its Metabolites in Vitro: Cytochromes Mediating Biotransformation, Inhibitory Effects, and Comparison to R-Citalopram
      Lisa L. von Moltke, David J. Greenblatt, Gina M. Giancarlo, Brian W. Granda, Jerold S. Harmatz and Richard I. Shader
      Drug Metabolism and Disposition August 2001, 29 (8) 1102-1109;

W

  1. Walters, David G.

    1. Identification of Cytochrome P-450 Isoforms Responsible for cis-Tramadol Metabolism in Human Liver Microsomes
      Vangala Subrahmanyam, Anthony B. Renwick, David G. Walters, Philip J. Young, Roger J. Price, Alfred P. Tonelli and Brian G. Lake
      Drug Metabolism and Disposition August 2001, 29 (8) 1146-1155;

  2. Wang, Er-jia

    1. Evaluation of the Interaction of Loratadine and desloratadine with P-glycoprotein
      Er-jia Wang, Christopher N. Casciano, Robert P. Clement and William W. Johnson
      Drug Metabolism and Disposition August 2001, 29 (8) 1080-1083;

  3. Welshman, I. R.

    1. Pharmacokinetics, Metabolism, and Excretion of Linezolid following an Oral Dose of [14C]Linezolid to Healthy Human Subjects
      J. G. Slatter, D. J. Stalker, K. L. Feenstra, I. R. Welshman, J. B. Bruss, J. P. Sams, M. G. Johnson, P. E. Sanders, M. J. Hauer, P. E. Fagerness, R. P. Stryd, G. W. Peng and E. M. Shobe
      Drug Metabolism and Disposition August 2001, 29 (8) 1136-1145;

  4. Williams, Susanne N.

    1. The Use of a High-Volume Screening Procedure to Assess the Effects of Dietary Flavonoids on Human CYP1A1 Expression
      Scott W. Allen, Lisa Mueller, Susanne N. Williams, Linda C. Quattrochi and Judy Raucy
      Drug Metabolism and Disposition August 2001, 29 (8) 1074-1079;

Y

  1. Yamazaki, Hiroshi

    1. Inhibition and Inactivation of Human Cytochrome P450 Isoforms by Phenethyl Isothiocyanate
      Miki Nakajima, Ryoko Yoshida, Noriaki Shimada, Hiroshi Yamazaki and Tsuyoshi Yokoi
      Drug Metabolism and Disposition August 2001, 29 (8) 1110-1113;

  2. Yokoi, Tsuyoshi

    1. Inhibition and Inactivation of Human Cytochrome P450 Isoforms by Phenethyl Isothiocyanate
      Miki Nakajima, Ryoko Yoshida, Noriaki Shimada, Hiroshi Yamazaki and Tsuyoshi Yokoi
      Drug Metabolism and Disposition August 2001, 29 (8) 1110-1113;

  3. Yokota, Hiroshi

    1. Bisphenol A Glucuronide, a Major Metabolite in Rat Bile after Liver Perfusion
      Hiroki Inoue, Hiroshi Yokota, Tsunehisa Makino, Akira Yuasa and Seiyu Kato
      Drug Metabolism and Disposition August 2001, 29 (8) 1084-1087;

  4. Yoshida, Ryoko

    1. Inhibition and Inactivation of Human Cytochrome P450 Isoforms by Phenethyl Isothiocyanate
      Miki Nakajima, Ryoko Yoshida, Noriaki Shimada, Hiroshi Yamazaki and Tsuyoshi Yokoi
      Drug Metabolism and Disposition August 2001, 29 (8) 1110-1113;

  5. Young, Philip J.

    1. Identification of Cytochrome P-450 Isoforms Responsible for cis-Tramadol Metabolism in Human Liver Microsomes
      Vangala Subrahmanyam, Anthony B. Renwick, David G. Walters, Philip J. Young, Roger J. Price, Alfred P. Tonelli and Brian G. Lake
      Drug Metabolism and Disposition August 2001, 29 (8) 1146-1155;

  6. Yuasa, Akira

    1. Bisphenol A Glucuronide, a Major Metabolite in Rat Bile after Liver Perfusion
      Hiroki Inoue, Hiroshi Yokota, Tsunehisa Makino, Akira Yuasa and Seiyu Kato
      Drug Metabolism and Disposition August 2001, 29 (8) 1084-1087;
Back to top

In this issue